Photosensitivity

 

Photosensitivity is a tendency to sunburn easily. Many drugs cause photosensitivity, including some chemotherapy drugs. Protecting your skin from the sun is very important. If you should get a severe sunburn, treatment is aimed at reducing inflammation and relieving pain.

What is photosensitivity?

Photosensitivity is an enhanced skin response to ultraviolet radiation (sunlight). This means that you may sunburn easily. A sunburn that you got within a week before chemotherapy may reappear, or rarely, a sunburn may spread to skin that was not exposed to the sun.

What causes photosensitivity?

There are many drugs that may cause photosensitivity. Chemotherapy drugs commonly associated with photosensitivity include:

  • DTIC-Dome® (dacarbazine)
  • 5-FU (fluorouracil)
  • Methotrexate
  • Velban® (vinblastine)
  • What are the symptoms of photosensitivity?

  • Symptoms of a sunburn include:
  • Redness
  • Inflammation
  • Blistering
  • Weeping
  • Peeling

What is the treatment for photosensitivity?

The treatments for a rash that results from photosensitivity aim to reduce inflammation and relieve pain.

Corticosteroid cream - Steroids work by reducing inflammation. Your doctor may prescribe a corticosteroid cream that you rub on the rash.

Analgesics - These over-the-counter medications can relieve pain associated with a rash. Examples are acetaminophen or aspirin.

What else can I do?

It is very important to protect your skin from the sun by following these tips:

  • Wear long sleeves and long pants.
  • Wear a wide brimmed hat.
  • Wear light, cotton gloves.
  • Use sunscreen on the skin that you cannot cover.
  • Sunblock with physical barrier such as zinc oxide may be necessary for vulnerable areas, such as the hands and nose.

For more information on having sensible fun in the sun, see Sun Sense.

This content was last modified on August 24, 2007 .
Latest Cancer News
Vaccine Against HPV-16 Effective for Vulvar Intraepithelial Neoplasia

November 6, 2009 — Researchers from the Netherlands have reported that vaccination with synthetic long-peptides against human papillomavirus (HPV)-16 was effective in treating vulvar intraepithelial neoplasia (VIN). The details of this study were published in the November 5, 2009 issue of the New England Journal of Medicine.

Small HER2-positive Breast Cancers Have a Higher Risk of Recurrence

November 6, 2009 — Researchers from the M. D. Anderson Cancer Center and the University of Milan, Italy, have reported that women with Stage T1a,b, N0M0 HER2-positive breast cancers have a have a high recurrence rate without the administration of adjuvant chemotherapy or Herceptin® (trastuzumab). These data suggest that these women should be treated with Herceptin®-based adjuvant chemotherapy. The details of these two studies appeared in early online publications on November 2, 2009 in the Journal of Clinical Oncology.

Alcohol May Reduce Risk of Thyroid Cancer

November 6, 2009 — Researchers affiliated with the NIH-AARP Diet and Health Study have reported that alcohol intake may reduce the risk of thyroid cancer. The details of this study appeared in the November 4, 2009 issue of the British Journal of Cancer.

Select news items provided by Reuters Health